Can Medicare Afford to Foot the Bill for New Alzheimer’s Drugs?
Recent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.
Read MoreRecent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.
Read MoreA recent NBER working paper looks at the effects of immigration into the U.S. on the staffing and quality of nursing homes.
Read MoreWhat’s gained and what’s lost as private insurers manage an increasingly large share of the Medicare program?
Read MoreWhat stops seriously ill Black patients and their families from getting the care they want in life and in death?
Read MoreThere’s a severe shortage of people to care for older Americans. Could providing workers with new career pathways be part of the solution?
Read MoreLeslie Walker shares four research studies to explain the stakes of Medicare open enrollment.
Read MoreYaa Akosa Antwi shares research on nursing home deaths during COVID suggesting even well-intentioned policies can have unintended consequences.
Read More